This is the logo of the provider
ECO 2025 11 - 14 May 2025

Early Clinical Benefit of Semaglutide in Adults with Overweight or Obesity and Cardiovascular Disease: A Secondary Analysis of the SELECT Trial

Authors :

Jorge Plutzky1; John W. Ostrominski1; Vanita R. Aroda2; John Deanfield3; Scott S. Emerson4; G. Kees Hovingh5; Steven E. Kahn6; Sergio Leonardi7; Ildiko Lingvay8; Donna H. Ryan9; Søren Rasmussen5; Benjamin M. Scirica10; Signe Stensen5; Peter E. Weeke5; A. Michael Lincoff11 

Affiliations
View Details Hide Details
This is the logo of the provider
{{ getPageNum(PDFPage) }}
Keywords
Obesity
Cardiovascular Disease
Congress oral presentation
GLP-1 RA
Semaglutide
PHASE 3 (RCT)